ARTICLE | Company News
Ablynx, Merck deal
October 8, 2012 7:00 AM UTC
Ablynx partnered with Merck to develop and commercialize Ablynx's Nanobodies targeting an undisclosed voltage-gated ion channel. The deal includes an option to develop and commercialize a Nanobody aga...